Periodontal disease associates with higher brain amyloid load in normal elderly

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 627-633

  Kamer, Angela R ^a,b   Pirraglia, Elizabeth ^b   Tsui, Wai ^b   Rusinek, Henry ^b,c   Vallabhajosula, Shankar ^d   Mosconi, Lisa ^b   Yi, Li ^b   McHugh, Pauline ^b   Craig, Ronald G ^a   Svetcov, Spencer ^a   Linker, Ross ^a   Shi, Chen ^a   Glodzik, Lidia ^b   Williams, Schantel ^b   Corby, Patricia ^a,e   Saxena, Deepak ^a   de Leon, Mony J ^b  

^a NEW YORK UNIVERSITY   (United States)

^b Center for Brain Health   (United States)

^c Jaffe Food Allergy Institute   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Alzheimer's disease; Brain amyloid; Cognition; Infection; Inflammation; Periodontal disease; PIB PET

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PITTSBURGH COMPOUND B; CARBON; DIETHYL-1,3,6,8-TETRAHYDRO-1,3,6,8-TETRAOXOBENZO(LMN)(3,8)PHENANTHROLINE-2,7-DIACETATE; PHENANTHROLINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AMYLOID NEUROPATHY; ARTICLE; BIOACCUMULATION; BLEEDING ON PROBING; CLINICAL ARTICLE; CLINICAL ATTACHMENT LOSS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; MALE; MEDICAL HISTORY; NEUROIMAGING; PERIODONTAL DISEASE; PERIODONTAL EXAMINATION; PERIODONTITIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN LOCALIZATION; SMOKING; SYMPTOM; ALZHEIMER DISEASE; ANIMAL; BRAIN; COMPLICATION; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CARBON RADIOISOTOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PHENANTHROLINES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS;

EID: 84922903212     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.038     Document Type: Article

References (83)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 2014, 10:e47-e92. Alzheimer's Association.
3. Anstey K.J., von Sanden C., Salim A., O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 2007, 166:367-378.
4. Barba R., Zapatero A., Losa J.E., Valdes V., Todoli J.A., Di Micco P., Monreal M., Riete I. Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J.Thromb. Haemost. 2008, 6:595-600.
5. Beck J.D., Elter J.R., Heiss G., Couper D., Mauriello S.M., Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1816-1822.
6. Beekly D.L., Ramos E.M., Lee W.W., Deitrich W.D., Jacka M.E., Wu J., Hubbard J.L., Koepsell T.D., Morris J.C., Kukull W.A. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis. Assoc. Disord. 2007, 21:249-258. NIA Alzheimer's Disease Centers.
7. Berg L. Clinical dementia rating. Br. J. Psychiatry 1984, 145:339.
8. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18:351-357.
9. Brenner D.E., Kukull W.A., van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993, 43:293-300.
10. Castellani R.J., Lee H.G., Siedlak S.L., Nunomura A., Hayashi T., Nakamura M., Zhu X., Perry G., Smith M.A. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J.Alzheimers Dis. 2009, 18:447-452.
11. Cataldo J.K., Prochaska J.J., Glantz S.A. Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation. J.Alzheimers Dis. 2010, 19:465-480.
12. Cavrini F., Sambri V., Moter A., Servidio D., Marangoni A., Montebugnoli L., Foschi F., Prati C., Di Bartolomeo R., Cevenini R. Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J.Med. Microbiol. 2005, 54(Pt 1):93-96.
13. Cockrell J.R., Folstein M.F. Mini-mental state examination (MMSE). Psychopharmacol. Bull. 1988, 24:689-692.
14. De Santi S., Pirraglia E., Barr W., Babb J., Williams S., Rogers K., Glodzik L., Brys M., Mosconi L., Reisberg B., Ferris S., de Leon M.J. Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology 2008, 22:469-484.
15. Demmer R.T., Kocher T., Schwahn C., Volzke H., Jacobs D.R., Desvarieux M. Refining exposure definitions for studies of periodontal disease and systemic disease associations. Community Dent. Oral Epidemiol. 2008, 36:493-502.
16. Eke P.I., Dye B.A., Wei L., Thornton-Evans G.O., Genco R.J. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J.Dent. Res. 2012, 91:914-920. CDC Periodontal Disease Surveillance Workgroup: James Beck, Gordon Douglass, Roy Page.
17. Ekuni D., Endo Y., Tomofuji T., Azuma T., Irie K., Kasuyama K., Morita M. Effects of apoE deficiency and occlusal disharmony on amyloid-beta production and spatial memory in rats. PLoS One 2013, 8:e74966.
18. Ellefsen B., Holm-Pedersen P., Morse D.E., Schroll M., Andersen B.B., Waldemar G. Caries prevalence in older persons with and without dementia. J.Am. Geriatr. Soc. 2008, 56:59-67.
19. Ellefsen B., Holm-Pedersen P., Morse D.E., Schroll M., Andersen B.B., Waldemar G. Assessing caries increments in elderly patients with and without dementia: a one-year follow-up study. J.Am. Dent. Assoc. 2009, 140:1392-1400.
20. Elter J.R., Champagne C.M., Offenbacher S., Beck J.D. Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J.Periodontol. 2004, 75:782-790.
21. Erickson M.A., Hartvigson P.E., Morofuji Y., Owen J.B., Butterfield D.A., Banks W.A. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J.Neuroinflammation 2012, 9:150-165.
22. Gatz M., Mortimer J.A., Fratiglioni L., Johansson B., Berg S., Reynolds C.A., Pedersen N.L. Potentially modifiable risk factors for dementia in identical twins. Alzheimers Dement. 2006, 2:110-117.
23. Grabe H.J., Schwahn C., Volzke H., Spitzer C., Freyberger H.J., John U., Mundt T., Biffar R., Kocher T. Tooth loss and cognitive impairment. J.Clin. Periodontol. 2009, 36:550-557.
24. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 1998, 8:65-72.
25. Haffajee A.D., Socransky S.S. Introduction to microbial aspects of periodontal biofilm communities, development and treatment. Periodontol. 2000 2006, 42:7-12.
26. Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., Genco R.J. Identification of periodontal pathogens in atheromatous plaques. J.Periodontol. 2000, 71:1554-1560.
27. Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R.W., Bullock R., Love S., Neal J.W., Zotova E., Nicoll J.A. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008, 372:216-223.
28. Holmes C., Butchart J. Systemic inflammation and Alzheimer's disease. Biochem. Soc. Trans. 2011, 39:898-901.
29. Holmes C., Cotterell D. Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 2009, 23:993-1002.
30. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132(Pt 5):1355-1365.
31. Jonsson D., Spinell T., Vrettos A., Stocklin-Wasmer C., Celenti R., Demmer R.T., Kebschull M., Papapanou P.N. Circulating endothelial progenitor cells in periodontitis. J.Periodontol. 2014, 85:1-14.
32. Kamer A.R., Craig R.G., Dasanayake A.P., Brys M., Glodzik-Sobanska L., de Leon M.J. Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement. 2008, 4:242-250.
33. Kamer A.R., Dasanayake A.P., Craig R.G., Glodzik-Sobanska L., Bry M., de Leon M.J. Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J.Alzheimers. Dis. 2008, 13:437-449.
34. Kamer A.R., Morse D.E., Holm-Pedersen P., Mortensen E.L., Avlund K. Periodontal inflammation in relation to cognitive function in an older adult Danish population. J.Alzheimers Dis. 2012, 28:613-624.
35. Kaye E.K., Valencia A., Baba N., Spiro A., Dietrich T., Garcia R.I. Tooth loss and periodontal disease predict poor cognitive function in older men. J.Am. Geriatr. Soc. 2010, 58:713-718.
36. Kiddle S.J., Thambisetty M., Simmons A., Riddoch-Contreras J., Hye A., Westman E., Pike I., Ward M., Johnston C., Lupton M.K., Lunnon K., Soininen H., Kloszewska I., Tsolaki M., Vellas B., Mecocci P., Lovestone S., Newhouse S., Dobson R. Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One 2012, 7:e44260. Alzheimers Disease Neuroimaging Initiative.
37. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
38. Kok E., Haikonen S., Luoto T., Huhtala H., Goebeler S., Haapasalo H., Karhunen P.J. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann. Neurol. 2009, 65:650-657.
39. Landau S.M., Marks S.M., Mormino E.C., Rabinovici G.D., Oh H., O'Neil J.P., Wilson R.S., Jagust W.J. Association of lifetime cognitive engagement and low beta-amyloid deposition. Arch. Neurol. 2012, 69:623-629.
40. Li Y., Rinne J.O., Mosconi L., Pirraglia E., Rusinek H., DeSanti S., Kemppainen N., Nagren K., Kim B.C., Tsui W., de Leon M.J. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2169-2181.
41. McGeer P.L., Rogers J., McGeer E.G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J.Alzheimers Dis. 2006, 9(3 Suppl):271-276.
42. Miklossy J. Alzheimer's disease-a spirochetosis?. Neuroreport 1993, 4:1069.
43. Miklossy J. Chronic inflammation and amyloidogenesis in Alzheimer's disease-role of Spirochetes. J.Alzheimers Dis. 2008, 13:381-391.
44. Miklossy J. Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J.Neuroinflammation 2011, 8:90-106.
45. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev. Mol. Med. 2011, 13:e30-e64.
46. Miklossy J., Kasas S., Janzer R.C., Ardizzoni F., Van der Loos H. Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease. Neuroreport 1994, 5:1201-1204.
47. Miklossy J., Khalili K., Gern L., Ericson R.L., Darekar P., Bolle L., Hurlimann J., Paster B.J. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J.Alzheimers Dis. 2004, 6:639-649. discussion 73-81.
48. Miklossy J., Kis A., Radenovic A., Miller L., Forro L., Martins R., Reiss K., Darbinian N., Darekar P., Mihaly L., Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol. Aging 2006, 27:228-236.
49. Moreno-Gonzalez I., Estrada L.D., Sanchez-Mejias E., Soto C. Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. Nat. Commun. 2013, 4:1495.
50. Morgan D. Immunotherapy for Alzheimer's disease. J.Intern. Med. 2011, 269:54-63.
51. Mosconi L., Andrews R.D., Matthews D.C. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. J.Alzheimers Dis. 2013, 35:509-524.
52. Mosconi L., Rinne J.O., Tsui W.H., Berti V., Li Y., Wang H., Murray J., Scheinin N., Nagren K., Williams S., Glodzik L., De Santi S., Vallabhajosula S., de Leon M.J. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5949-5954.
53. Mosconi L., Rinne J.O., Tsui W.H., Murray J., Li Y., Glodzik L., McHugh P., Williams S., Cummings M., Pirraglia E., Goldsmith S.J., Vallabhajosula S., Scheinin N., Viljanen T., Nagren K., de Leon M.J. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol. Aging 2013, 34:22-34.
54. Mosconi L., Tsui W.H., De Santi S., Li J., Rusinek H., Convit A., Li Y., Boppana M., de Leon M.J. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005, 64:1860-1867.
55. Mosconi L., Tsui W., Murray J., McHugh P., Li Y., Williams S., Pirraglia E., Glodzik L., De Santi S., Vallabhajosula S., de Leon M.J. Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease. Neurobiol. Aging 2012, 33:624.e1-624.e9.
56. Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J.Cereb. Blood Flow Metab. 1992, 12:571-583.
57. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
58. Noble J.M., Borrell L.N., Papapanou P.N., Elkind M.S., Scarmeas N., Wright C.B. Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J.Neurol. Neurosurg. Psychiatry 2009, 80:1206-1211.
59. Okuda K., Ishihara K., Nakagawa T., Hirayama A., Inayama Y., Okuda K. Detection of Treponema denticola in atherosclerotic lesions. J.Clin. Microbiol. 2001, 39:1114-1117.
60. Osorio R.S., Pirraglia E., Gumb T., Mantua J., Ayappa I., Williams S., Mosconi L., Glodzik L., de Leon M.J. Imaging and cerebrospinal fluid biomarkers in the search for Alzheimer's disease mechanisms. Neurodegener. Dis. 2014, 13:163-165.
61. Ozudogru S.N., Lippa C.F. Disease modifying drugs targeting beta-amyloid. Am. J. Alzheimers Dis. Other Demen. 2012, 27:296-300.
62. Page R.C., Eke P.I. Case definitions for use in population-based surveillance of periodontitis. J.Periodontol. 2007, 78(7 Suppl):1387-1399.
63. Paraskevas S., Huizinga J.D., Loos B.G. Asystematic review and meta-analyses on C-reactive protein in relation to periodontitis. J.Clin. Periodontol. 2008, 35:277-290.
64. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4:103-112.
65. Poole S., Singhrao S.K., Kesavalu L., Curtis M.A., Crean S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J.Alzheimers Dis. 2013, 36:665-677.
66. Reichert S., Haffner M., Keysser G., Schafer C., Stein J.M., Schaller H.G., Wienke A., Strauss H., Heide S., Schulz S. Detection of oral bacterial DNA in synovial fluid. J.Clin. Periodontol. 2013, 40:591-598.
67. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982, 139:1136-1139.
68. Reitz C., Brayne C., Mayeux R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 2011, 7:137-152.
69. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
70. Riviere G.R., Riviere K.H., Smith K.S. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol. Immunol. 2002, 17:113-118.
71. Ship J.A. Oral health of patients with Alzheimer's disease. J.Am. Dent. Assoc. 1992, 123:53-58.
72. Silness J., Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol. Scand. 1964, 22:121-135.
73. Socransky S.S., Haffajee A.D. The nature of periodontal diseases. Ann. Periodontol. 1997, 2:3-10.
74. Socransky S.S., Haffajee A.D. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002, 28:12-55.
75. Soscia S.J., Kirby J.E., Washicosky K.J., Tucker S.M., Ingelsson M., Hyman B., Burton M.A., Goldstein L.E., Duong S., Tanzi R.E., Moir R.D. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010, 5:e9505-e9515.
76. Sparks Stein P., Steffen M.J., Smith C., Jicha G., Ebersole J.L., Abner E., Dawson D. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement. 2012, 8:196-203.
77. Stein P.S., Desrosiers M., Donegan S.J., Yepes J.F., Kryscio R.J. Tooth loss, dementia and neuropathology in the Nun Study. J.Am. Dent. Assoc. 2007, 138:1314-1322.
78. Stewart R., Hirani V. Dental health and cognitive impairment in an English national survey population. J.Am. Geriatr. Soc. 2007, 55:1410-1414.
79. Tanzi R.E. The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:1-10.
80. Tonetti M.S., Claffey N. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J.Clin. Periodontol. 2005, 32(Suppl 6):210-213. European Workshop in Periodontology group, C.
81. Weintraub M.K., Bisson C.M., Nouri J.N., Vinson B.T., Eimerbrink M.J., Kranjac D., Boehm G.W., Chumley M.J. Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure. Brain Behav. Immun. 2013, 33:24-28.
82. White M.R., Kandel R., Tripathi S., Condon D., Qi L., Taubenberger J., Hartshorn K.L. Alzheimer's associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One 2014, 9:e101364.
83. Yu Y.H., Kuo H.K. Association between cognitive function and periodontal disease in older adults. J.Am. Geriatr. Soc. 2008, 56:1693-1697.